HILL INTERNATIONAL INC (HIL)

US4314661012 - Common Stock

3.4  +0.02 (+0.59%)

Fundamental Rating

2

Taking everything into account, HIL scores 2 out of 10 in our fundamental rating. HIL was compared to 80 industry peers in the Professional Services industry. HIL may be in some trouble as it scores bad on both profitability and health. HIL is valued expensive and it does not seem to be growing.



1

1. Profitability

1.1 Basic Checks

In the past year HIL was profitable.
HIL had a negative operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: HIL reported negative net income in multiple years.
In multiple years HIL reported negative operating cash flow during the last 5 years.

1.2 Ratios

The profitability ratios for HIL are negative, so there is not much use analyzing them.
HIL has a Return On Invested Capital (6.55%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for HIL is significantly below the industry average of 18.09%.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 6.55%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)8.81%
ROIC(5y)N/A

1.3 Margins

Looking at the Operating Margin, with a value of 3.21%, HIL is doing worse than 69.70% of the companies in the same industry.
HIL does not have Profit Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM 3.21%
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), HIL is creating some value.
The number of shares outstanding for HIL has been increased compared to 1 year ago.
HIL has a worse debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 2.12 indicates that HIL is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of HIL (2.12) is worse than 65.15% of its industry peers.
HIL has a Debt/Equity ratio of 0.30. This is a healthy value indicating a solid balance between debt and equity.
HIL has a Debt to Equity ratio (0.30) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF N/A
Altman-Z 2.12
ROIC/WACC0.78
WACC8.37%

2.3 Liquidity

HIL has a Current Ratio of 1.59. This is a normal value and indicates that HIL is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.59, HIL is in line with its industry, outperforming 54.55% of the companies in the same industry.
HIL has a Quick Ratio of 1.59. This is a normal value and indicates that HIL is financially healthy and should not expect problems in meeting its short term obligations.
HIL has a Quick ratio (1.59) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.59

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1729382256910270464.00% over the past year.
The Revenue has grown by 8.58% in the past year. This is quite good.
HIL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.06% yearly.
EPS 1Y (TTM)1729382256910270500%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-120%
Revenue 1Y (TTM)8.58%
Revenue growth 3Y-4.16%
Revenue growth 5Y-6.06%
Sales Q2Q%13.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 113.33 indicates a quite expensive valuation of HIL.
Based on the Price/Earnings ratio, HIL is valued a bit more expensive than 77.27% of the companies in the same industry.
HIL is valuated expensively when we compare the Price/Earnings ratio to 29.29, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 113.33
Fwd PE N/A

4.2 Price Multiples

HIL's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.95

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for HIL!.
Industry RankSector Rank
Dividend Yield N/A

HILL INTERNATIONAL INC

NYSE:HIL (12/23/2022, 8:04:00 PM)

3.4

+0.02 (+0.59%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap194.10M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 113.33
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM 3.21%
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.59
Quick Ratio 1.59
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)1729382256910270500%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)8.58%
Revenue growth 3Y-4.16%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y